David P. Nunes, MD

Associate Professor, Medicine

David Nunes
85 E. Concord St


Expertise includes: Clinical liver disease – interest in viral hepatitis; Evaluation and management of liver lesions.

Other Positions

  • Active Staff Privileges, Medicine, Boston Medical Center


  • Trinity College, MBBCh


  • Published on 9/1/2019

    Gilad A, Fricker ZP, Hsieh A, Thomas DD, Zahorian T, Nunes DP. Sustained Improvement in Type 2 Diabetes Mellitus is Common After Treatment of Hepatitis C Virus With Direct-acting Antiviral Therapy. J Clin Gastroenterol. 2019 Sep; 53(8):616-620. PMID: 30614943.

    Read at: PubMed
  • Published on 4/3/2019

    Pratt PK, Nunes D, Long MT, Farraye FA. Improved Antibody Response to Three Additional Hepatitis B Vaccine Doses Following Primary Vaccination Failure in Patients with Inflammatory Bowel Disease. Dig Dis Sci. 2019 07; 64(7):2031-2038. PMID: 30945037.

    Read at: PubMed
  • Published on 8/4/2018

    Tran AN, Sachdev R, Fricker ZP, Leber M, Zahorian T, Shah B, Nunes DP, Long MT. Intensive Pharmacy Care Improves Outcomes of Hepatitis C Treatment in a Vulnerable Patient Population at a Safety-Net Hospital. Dig Dis Sci. 2018 12; 63(12):3241-3249. PMID: 30078116.

    Read at: PubMed
  • Published on 4/1/2018

    Reddy YNV, Nunes D, Chitalia V, Gordon CE, Francis JM. Hepatitis C virus infection in kidney transplantation-changing paradigms with novel agents. Hemodial Int. 2018 04; 22 Suppl 1:S53-S60. PMID: 29694721.

    Read at: PubMed
  • Published on 12/31/2015

    Baranoski AS, Cotton D, Heeren T, Nunes D, Kubiak RW, Horsburgh CR. Clinical Liver Disease Progression Among Hepatitis C-Infected Drug Users With CD4 Cell Count Less Than 200 Cells/mm(3) Is More Pronounced Among Women Than Men. Open Forum Infect Dis. 2016 Jan; 3(1):ofv214. PMID: 26955643.

    Read at: PubMed
  • Published on 2/28/2015

    Anderson JP, Horsburgh CR, Williams PL, Tchetgen Tchetgen EJ, Nunes D, Cotton D, Seage GR. CD4 recovery on antiretroviral therapy is associated with decreased progression to liver disease among hepatitis C virus-infected injecting drug users. Open Forum Infect Dis. 2015 Jan; 2(1):ofv019. PMID: 26034769.

    Read at: PubMed
  • Published on 10/24/2013

    Fuster D, Cheng DM, Quinn EK, Nunes D, Saitz R, Samet JH, Tsui JI. Chronic hepatitis C virus infection is associated with all-cause and liver-related mortality in a cohort of HIV-infected patients with alcohol problems. Addiction. 2014 Jan; 109(1):62-70. PMID: 24112091.

    Read at: PubMed
  • Published on 7/1/2013

    Okafor PN, Nunes DP, Farraye FA. Pneumocystis jiroveci pneumonia in inflammatory bowel disease: when should prophylaxis be considered? Inflamm Bowel Dis. 2013 Jul; 19(8):1764-71. PMID: 23615530.

    Read at: PubMed
  • Published on 5/17/2013

    Fuster D, Tsui JI, Cheng DM, Quinn EK, Armah KA, Nunes D, Freiberg MS, Samet JH. Interleukin-6 is associated with noninvasive markers of liver fibrosis in HIV-infected patients with alcohol problems. AIDS Res Hum Retroviruses. 2013 Aug; 29(8):1110-6. PMID: 23601055.

    Read at: PubMed
  • Published on 5/3/2013

    Fuster D, Tsui JI, Cheng DM, Quinn EK, Bridden C, Nunes D, Libman H, Saitz R, Samet JH. Impact of lifetime alcohol use on liver fibrosis in a population of HIV-infected patients with and without hepatitis C coinfection. Alcohol Clin Exp Res. 2013 Sep; 37(9):1527-35. PMID: 23647488.

    Read at: PubMed

View 46 more publications: View full profile at BUMC

View all profiles